Avicanna™ is positioned to be a front runner in the development, manufacturing and commercialization of plant-derived cannabinoid-based products and extracts throughout North America, Latin America.
Avicanna‘s team of scientists and researchers develop plant-derived cannabinoid formulations for medical applications and consumer products. This scientific and evidence-based approach has enabled Avicanna™ to offer portfolios of cannabinoid-based solutions for a range of channels and markets including derma-cosmetics, phyto-therapeutics and pharmaceutical products.
The company cultivates and processes cannabinoids through its two majority-owned subsidiaries, Sativa Nativa and Santa Marta Golden Hemp, both located in Santa Marta, Colombia.
Subsidiaries: Santa Marta Golden Hemp S.A.S., Sativa Nativa S.A.S., 2516167 Ontario Inc